PT1098885E - Compostos de imidazole e sua utilizacao como inibidores da desaminase de adenosina - Google Patents
Compostos de imidazole e sua utilizacao como inibidores da desaminase de adenosinaInfo
- Publication number
- PT1098885E PT1098885E PT99931497T PT99931497T PT1098885E PT 1098885 E PT1098885 E PT 1098885E PT 99931497 T PT99931497 T PT 99931497T PT 99931497 T PT99931497 T PT 99931497T PT 1098885 E PT1098885 E PT 1098885E
- Authority
- PT
- Portugal
- Prior art keywords
- hydroxy
- optionally substituted
- imidazole compounds
- dehymenase
- adenosin
- Prior art date
Links
- OIRDTQYFTABQOQ-KQYNXXCUSA-N adenosine Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O OIRDTQYFTABQOQ-KQYNXXCUSA-N 0.000 title abstract 4
- 201000010099 disease Diseases 0.000 title abstract 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 title abstract 2
- RAXXELZNTBOGNW-UHFFFAOYSA-N 1H-imidazole Chemical class C1=CNC=N1 RAXXELZNTBOGNW-UHFFFAOYSA-N 0.000 title 1
- 239000003112 inhibitor Substances 0.000 title 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 abstract 7
- 125000000217 alkyl group Chemical group 0.000 abstract 3
- 125000001424 substituent group Chemical group 0.000 abstract 3
- 125000003118 aryl group Chemical group 0.000 abstract 2
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 abstract 2
- 229910052739 hydrogen Inorganic materials 0.000 abstract 2
- 239000001257 hydrogen Substances 0.000 abstract 2
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 2
- 101710169336 5'-deoxyadenosine deaminase Proteins 0.000 abstract 1
- 102000055025 Adenosine deaminases Human genes 0.000 abstract 1
- 239000002126 C01EB10 - Adenosine Substances 0.000 abstract 1
- 229960005305 adenosine Drugs 0.000 abstract 1
- 125000002947 alkylene group Chemical group 0.000 abstract 1
- 125000003917 carbamoyl group Chemical group [H]N([H])C(*)=O 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 125000004093 cyano group Chemical group *C#N 0.000 abstract 1
- 125000000623 heterocyclic group Chemical group 0.000 abstract 1
- 150000002460 imidazoles Chemical class 0.000 abstract 1
- 230000002401 inhibitory effect Effects 0.000 abstract 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 abstract 1
- 229940002612 prodrug Drugs 0.000 abstract 1
- 239000000651 prodrug Substances 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D233/90—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
- C07F7/02—Silicon compounds
- C07F7/08—Compounds having one or more C—Si linkages
- C07F7/18—Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
- C07F7/1804—Compounds having Si-O-C linkages
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Cardiology (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Hematology (AREA)
- Heart & Thoracic Surgery (AREA)
- Oncology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AUPP4840A AUPP484098A0 (en) | 1998-07-23 | 1998-07-23 | Novel imidazole compounds |
| AUPP7355A AUPP735598A0 (en) | 1998-11-27 | 1998-11-27 | Novel imidazole compounds |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PT1098885E true PT1098885E (pt) | 2005-01-31 |
Family
ID=25645831
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PT99931497T PT1098885E (pt) | 1998-07-23 | 1999-07-22 | Compostos de imidazole e sua utilizacao como inibidores da desaminase de adenosina |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US6359145B1 (pt) |
| EP (1) | EP1098885B9 (pt) |
| JP (1) | JP4525883B2 (pt) |
| KR (1) | KR100429754B1 (pt) |
| CN (1) | CN1291979C (pt) |
| AT (1) | ATE282599T1 (pt) |
| BR (1) | BR9912684A (pt) |
| CA (1) | CA2338305A1 (pt) |
| DE (1) | DE69922009T2 (pt) |
| ES (1) | ES2234269T3 (pt) |
| HK (1) | HK1041264B (pt) |
| HU (1) | HUP0103303A3 (pt) |
| MX (1) | MXPA01000549A (pt) |
| PT (1) | PT1098885E (pt) |
| RU (1) | RU2243220C2 (pt) |
| WO (1) | WO2000005217A1 (pt) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AUPP921299A0 (en) | 1999-03-15 | 1999-04-15 | Fujisawa Pharmaceutical Co., Ltd. | New heterocyclic compounds |
| US6103702A (en) * | 1999-05-24 | 2000-08-15 | Board Of Trustees Of The University Of Illinois | Use of adenosine deaminase inhibitors to treat systemic inflammatory response syndrome |
| AUPQ515700A0 (en) * | 2000-01-19 | 2000-02-10 | Fujisawa Pharmaceutical Co., Ltd. | Imidazole compounds |
| AUPR636301A0 (en) * | 2001-07-13 | 2001-08-02 | Fujisawa Pharmaceutical Co., Ltd. | Imidazole compounds |
| AUPS058102A0 (en) * | 2002-02-15 | 2002-03-14 | Fujisawa Pharmaceutical Co., Ltd. | Imidazole compounds |
| US20040175804A1 (en) * | 2003-03-04 | 2004-09-09 | Skonezny Paul M. | Process for preparing dideoxyinosine using adenosine deaminase enzyme |
| TW200815388A (en) * | 2006-04-18 | 2008-04-01 | Wyeth Corp | Chromane and chromene derivatives and uses thereof |
| US7666893B2 (en) * | 2006-05-23 | 2010-02-23 | Meddev Inc. | Method for treatment of neurodegenerative disorders |
| US8314136B1 (en) | 2006-05-23 | 2012-11-20 | MedDEV, Inc. | Method for treatment of alzheimer's disease and autism spectrum disorders |
| JP2010529189A (ja) * | 2007-06-11 | 2010-08-26 | ファレッタ ヘルス イーペー エーエー ベー．フェー． | 免疫関連疾患および炎症性疾患の処置に有用なウロカニン酸誘導体 |
| JP5454458B2 (ja) * | 2010-11-25 | 2014-03-26 | 信越化学工業株式会社 | ポジ型レジスト材料及びパターン形成方法 |
| CN108318594A (zh) * | 2018-01-12 | 2018-07-24 | 上海中医药大学 | 一种液相色谱串联质谱法测定腺苷脱氨酶活性及筛选其抑制剂的方法 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB8906965D0 (en) * | 1989-03-28 | 1989-05-10 | Schering Agrochemicals Ltd | Fungicides |
| DE69401486T2 (de) * | 1993-11-12 | 1997-04-30 | Ishihara Sangyo Kaisha | Verfahren zur Herstellung 2-cyanoimidazol Derivate |
| CA2261591A1 (en) * | 1996-07-15 | 1998-01-22 | Elie Abushanab | Adenosine deaminase inhibitors |
-
1999
- 1999-07-22 WO PCT/JP1999/003939 patent/WO2000005217A1/en active IP Right Grant
- 1999-07-22 US US09/764,995 patent/US6359145B1/en not_active Expired - Fee Related
- 1999-07-22 BR BR9912684-2A patent/BR9912684A/pt not_active IP Right Cessation
- 1999-07-22 ES ES99931497T patent/ES2234269T3/es not_active Expired - Lifetime
- 1999-07-22 HU HU0103303A patent/HUP0103303A3/hu unknown
- 1999-07-22 RU RU2001105092/04A patent/RU2243220C2/ru not_active IP Right Cessation
- 1999-07-22 KR KR10-2001-7000976A patent/KR100429754B1/ko not_active IP Right Cessation
- 1999-07-22 AT AT99931497T patent/ATE282599T1/de active
- 1999-07-22 JP JP2000561173A patent/JP4525883B2/ja not_active Expired - Fee Related
- 1999-07-22 DE DE69922009T patent/DE69922009T2/de not_active Expired - Lifetime
- 1999-07-22 EP EP99931497A patent/EP1098885B9/en not_active Expired - Lifetime
- 1999-07-22 PT PT99931497T patent/PT1098885E/pt unknown
- 1999-07-22 CA CA002338305A patent/CA2338305A1/en not_active Abandoned
- 1999-07-22 CN CNB998111090A patent/CN1291979C/zh not_active Expired - Fee Related
- 1999-07-22 MX MXPA01000549A patent/MXPA01000549A/es not_active IP Right Cessation
-
2002
- 2002-04-22 HK HK02103021.5A patent/HK1041264B/zh not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| HUP0103303A2 (hu) | 2002-04-29 |
| HUP0103303A3 (en) | 2002-09-30 |
| HK1041264A1 (en) | 2002-07-05 |
| EP1098885B1 (en) | 2004-11-17 |
| CN1291979C (zh) | 2006-12-27 |
| WO2000005217A1 (en) | 2000-02-03 |
| JP4525883B2 (ja) | 2010-08-18 |
| CN1319095A (zh) | 2001-10-24 |
| ES2234269T3 (es) | 2005-06-16 |
| ATE282599T1 (de) | 2004-12-15 |
| HK1041264B (zh) | 2007-08-17 |
| KR100429754B1 (ko) | 2004-05-03 |
| DE69922009D1 (de) | 2004-12-23 |
| JP2002521369A (ja) | 2002-07-16 |
| US6359145B1 (en) | 2002-03-19 |
| EP1098885B9 (en) | 2005-05-18 |
| KR20010072037A (ko) | 2001-07-31 |
| CA2338305A1 (en) | 2000-02-03 |
| MXPA01000549A (es) | 2002-04-08 |
| DE69922009T2 (de) | 2005-04-07 |
| BR9912684A (pt) | 2001-05-02 |
| EP1098885A1 (en) | 2001-05-16 |
| RU2243220C2 (ru) | 2004-12-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| TR200201505T2 (tr) | Terapötik maddeler olarak pirazolopirimidinler | |
| DE50302975D1 (de) | Neue xanthinderivate, deren herstellung und deren verwendung als arzneimittel | |
| BR0007527A (pt) | Fenilfenantridinas com atividade inibitória depde-iv | |
| TR200002617T2 (tr) | Aril ve heteroaril sübstitüentli heterosiklik üreler kullanılarak RAF kinazın inhibe edilmesi | |
| ES2175079T3 (es) | Derivados de indol utiles como inhibidores de cgmp-pde. | |
| BRPI0412347A (pt) | 2-aminofenil-4-fenilpiridinas como inibidores de quinase | |
| NO20060665L (no) | N-substituerte pyrazolyl-amidyl-benzimidazolyl C-kit inhibitorer | |
| TR200201205T2 (tr) | N-ikame edilmiş karbamoiloksialkil-azolyum türevleri. | |
| NO20060664L (no) | N-substituerte benzimidazolyl C-kit inhibitorer | |
| NO20021358D0 (no) | Alkylendiamin-substituerte heterocykler | |
| TR200100047T2 (tr) | Tiyobenzimidazol türevleri | |
| EA200501009A1 (ru) | Замещённые пирролопиразольные производные в качестве ингибиторов киназы | |
| DE69425162D1 (de) | 4,5-diaryloxazol-derivate | |
| ATE253545T1 (de) | Biarylessigsäure-derivate und ihre verwendung als cox-2 inhibitoren | |
| ES2170252T3 (es) | Tetrahidroimidazopiridoindoldionas como inhibidores de cgmp especifico pde. | |
| EA199800184A1 (ru) | Соединение бензимидазола | |
| NO20070432L (no) | Pyrimidinureaderivater som kinaseinhibitorer | |
| IL114315A0 (en) | Heterocyclic compounds and pharmaceutical compositions containing the same for inhibiting phosphodiesterase IV | |
| ES2169472T3 (es) | Analogos de benzamida, utiles como inhibidores de la enzima de reparacion del dna denominada parp (adp-ribosiltransferasa, adprt). | |
| ATE292634T1 (de) | Inhibitoren der alpha-l beta-2 vermittelten zelladhäsion | |
| PT718293E (pt) | Composto ciclodepsipeptidico | |
| PT1098885E (pt) | Compostos de imidazole e sua utilizacao como inibidores da desaminase de adenosina | |
| BR0313385A (pt) | Derivados de pirimidina-2,4-diona como inibidores de metaloproteinase da matriz | |
| DE69924292D1 (de) | Pyrazol verbindungen und ihre verwendung | |
| PT729455E (pt) | Arilpiperazinas derivadas de indol como ligados para os receptores 5ht1-like, 5ht1b e 5ht1d |